Private Equity

Gastroenterology Associates of Northern Virginia, the leading provider of digestive health services in Northern Virginia, has been acquired by Gastro Health.

PE investment in gastroenterology will likely continue into 2020 — 3 insights – Abe M’Bodj, an associate at Provident, spoke to Becker’s ASC Review about the recent transactions and what’s on the horizon for the gastroenterology sector.

An orthopedic practice nearby could be considering PE backing — here’s why it matters – Robert Aprill, a senior associate at Provident, spoke to Becker’s ASC Review about the recent transactions and what’s on the horizon for orthopedics.

Orthopedic investments in Q3 + how ASCs can benefit from private equity attention – Two new private equity platforms were established in the orthopedic sector in the third quarter of 2019, according to Provident Healthcare Partners’ “Q3-2019 Physician Services Update.”

Q3-2019 Private Equity Industry Update– Q3 of 2019 saw private equity funds raise $163B in aggregate capital. Despite the high amount of available capital to be deployed, 2019 has shown decreasing trends in deal volume and capital invested relative to 2018. Downward trends are expected to prompt sellers to seek to exit while purchase multiples are high.

Health Care MarketTrends | September 2019, Issue 2 – Law Firm Foley & Lardner LLP examine private equity investment in specialty areas of the healthcare industry, specifically dermatology and orthopedics. The article includes insight from Provident Healthcare Partners.

Investment & Consolidation in Addiction Treatment– The Substance Abuse sector has experienced significant investment activity as rising demand and significant fragmentation within the sector continue to create a ripe environment for consolidation.

Market Trends and M&A in Home Health / Hospice– The home health and hospice market remains one of the most fragmented sectors within healthcare services with many independent players holding significant market share in their respective geographies. Given the wide breadth of smaller companies, demand for home-based care, and the non capital-intensive nature of the business, there is significant opportunity in the space for both private equity and strategic-led consolidation.

Private Equity in Orthopedics: Before, During and After the Transaction – On Tuesday August 27, Provident co-hosted a webinar with Frier Levitt which focused on providing an update on the current state of the market, discussing what physicians should think about as they consider a transaction, and outlining what typical transaction terms look like for practices.

Private Equity Accelerating Consolidation In The CDMO Market – Bill Bolding and AJ Shekar share their insight on consolidation in the CDMO space.

Q2-2019 Private Equity Industry Update– Dry powder in the European and North American markets is currently at a new high while market uncertainty has impacted deal volume during the first half of 2019.

Private Equity Investment in Gastroenterology 2.0 – On Tuesday, July 23, Provident co-hosted a webinar which provided an update on the current state of the GI Market. The recording for the webinar is now available.

Cannabis, Hemp Producers Targeted in May Health-Care Deals – The health-care industry is getting into the weed business.

The State of the Ophthalmology Sector Five Years into Private Equity Investment – On Thursday June 27, Provident co-hosted a webinar which educated ophthalmologists and executives on the current transaction environment within the ophthalmology sector. The recording for the webinar is now available.

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”